Correlation of P16 and Cyclin D1 Expression with the Incidence and Prognosis of Cardiac Carcinoma

Overview

Journal Oncol Lett

Specialty Oncology

Date 2019 Jun 13

PMID 31186693

Citations 1

Authors

Haoxun Wang

Jing Wang

Bingbo Zhao

Affiliations

Soon will be listed here.

Abstract

Correlation of p16 and cyclin D1 expression with the incidence and prognosis of cardiac carcinoma was investigated. Thirty-six patients with cardiac carcinoma treated in The Second Affiliated Hospital of Zhengzhou University were selected. After the radical operation of cardiac carcinoma, carcinoma tissues were taken, and the corresponding para-carcinoma tissues were used as controls. p16 and cyclin D1 messenger ribonucleic acid (mRNA) and protein expression in cardiac carcinoma tissues and para-carcinoma tissues were detected via quantitative polymerase chain reaction (qPCR) and western blot analysis. The survival time and pathological conditions of patients with cardiac carcinoma were recorded in detail, and correlation of p16 and cyclin D1 with incidence and prognosis of cardiac carcinoma was studied. In cardiac carcinoma tissues, the p16 mRNA and protein expression levels were significantly lower than those in para-carcinoma tissues (P<0.01), but the cyclin D1 mRNA and protein expression levels were significantly higher than those in para-carcinoma tissues (P<0.01). The expression of p16 and cyclin D1 protein had correlation with the tumor size, lymph node metastasis and tumor-node-metastasis stage of cardiac carcinoma (P<0.01). There was a negative correlation between expression of p16 and cyclin D1 in cardiac carcinoma (P<0.01). According to Kaplan-Meier survival analysis, the survival rate of patients with high expression of p16 was obviously higher than that of patients with low expression of p16 (P<0.01), while the survival rate of patients with high expression of cyclin D1 was obviously lower than that of patients with low expression of cyclin D1 (P<0.01). Both p16 and cyclin D1 are closely related to the incidence and prognosis of cardiac carcinoma, which may become indexes for the incidence and prognosis of cardiac carcinoma.

Citing Articles

SMAR1 inhibits proliferation, EMT and Warburg effect of bladder cancer cells by suppressing the activity of the Wnt/β-catenin signaling pathway.

Bao P, Li P, Zhou X, Zhang H, You S, Xu Z Cell Cycle. 2022; 22(2):229-241.

PMID: 35980125 PMC: 9817122. DOI: 10.1080/15384101.2022.2112006.

References

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

Liu T, Niu Y, Feng Y, Niu R, Yu Y, Lv A . Methylation of CpG islands of p16(INK4a) and cyclinD1 overexpression associated with progression of intraductal proliferative lesions of the breast. Hum Pathol. 2008; 39(11):1637-46. DOI: 10.1016/j.humpath.2008.04.001. View

Fu Z, Ma Z, Wang Q, Lei D, Wang R, Liu C . Overexpression of CyclinD1 and underexpression of p16 correlate with lymph node metastases in laryngeal squamous cell carcinoma in Chinese patients. Clin Exp Metastasis. 2008; 25(8):887-92. DOI: 10.1007/s10585-008-9207-x. View

Zhao X, Song T, He Z, Tang L, Zhu Y . A novel role of cyclinD1 and p16 in clinical pathology and prognosis of childhood medulloblastoma. Med Oncol. 2009; 27(3):985-91. DOI: 10.1007/s12032-009-9320-y. View

Feng Z, Chen J, Wei H, Gao P, Shi J, Zhang J . The risk factor of gallbladder cancer: hyperplasia of mucous epithelium caused by gallstones associates with p16/CyclinD1/CDK4 pathway. Exp Mol Pathol. 2011; 91(2):569-77. DOI: 10.1016/j.yexmp.2011.06.004. View

Wang H, Lv J . The Clinical Evaluation of Tegafur Gimeracil Oteracil Combined with THP and DDP for Second-Line Treatment of Advanced Cardiac Carcinoma. Cell Biochem Biophys. 2015; 72(3):695-9. DOI: 10.1007/s12013-015-0520-0. View

Dreyer J, Hauck F, Barros M, Niedobitek G . pRb and CyclinD1 Complement p16 as Immunohistochemical Surrogate Markers of HPV Infection in Head and Neck Cancer. Appl Immunohistochem Mol Morphol. 2015; 25(5):366-373. DOI: 10.1097/PAI.0000000000000309. View

Chen Y, Kang Y, Hong L, Yao H . Hypoglycemia caused by co-secretion of insulin from lung tumor and cardia cancer: first case report. Sao Paulo Med J. 2017; 137(1):100-103. PMC: 9721221. DOI: 10.1590/1516-3180.2017.0136060617. View

Liu J, Zhang Q, Wang Z . Clinicopathological significance of p16, cyclin D1, Rb and MIB-1 levels in skull base chordoma and chondrosarcoma. World J Otorhinolaryngol Head Neck Surg. 2017; 1(1):50-56. PMC: 5698503. DOI: 10.1016/j.wjorl.2015.09.005. View

10.

Tang Y, Berlind J, Mavila N . Inhibition of CREB binding protein-beta-catenin signaling down regulates CD133 expression and activates PP2A-PTEN signaling in tumor initiating liver cancer cells. Cell Commun Signal. 2018; 16(1):9. PMC: 5848530. DOI: 10.1186/s12964-018-0222-5. View

11.

Lachance J, Webber J, Hong L, Dinner A, Rebay I . Cooperative recruitment of Yan via a high-affinity ETS supersite organizes repression to confer specificity and robustness to cardiac cell fate specification. Genes Dev. 2018; 32(5-6):389-401. PMC: 5900712. DOI: 10.1101/gad.307132.117. View

12.

Padrao A, Nogueira-Ferreira R, Vitorino R, Carvalho D, Correia C, Neuparth M . Exercise training protects against cancer-induced cardiac remodeling in an animal model of urothelial carcinoma. Arch Biochem Biophys. 2018; 645:12-18. DOI: 10.1016/j.abb.2018.03.013. View

13.

Ong G, Brezden-Masley C, Dhir V, Deva D, Chan K, Chow C . Myocardial strain imaging by cardiac magnetic resonance for detection of subclinical myocardial dysfunction in breast cancer patients receiving trastuzumab and chemotherapy. Int J Cardiol. 2018; 261:228-233. DOI: 10.1016/j.ijcard.2018.03.041. View

14.

Zhou N, Gu Q . Prognostic and clinicopathological value of p16 protein aberrant expression in colorectal cancer: A PRISMA-compliant Meta-analysis. Medicine (Baltimore). 2018; 97(12):e0195. PMC: 5895319. DOI: 10.1097/MD.0000000000010195. View

15.

Prigenzi K, Heinke T, Salim R, de Azevedo Focchi G . Dual p16 and Ki-67 Expression in Liquid-Based Cervical Cytological Samples Compared to Pap Cytology Findings, Biopsies, and HPV Testing in Cervical Cancer Screening: A Diagnostic Accuracy Study. Acta Cytol. 2018; 62(2):104-114. DOI: 10.1159/000487504. View

16.

Xie C, Lin X, Wu D, Tan Y, Cheng C, Zhang J . Cardiac glycoside bufalin blocks cancer cell growth by inhibition of Aurora A and Aurora B activation via PI3K-Akt pathway. Oncotarget. 2018; 9(17):13783-13795. PMC: 5862615. DOI: 10.18632/oncotarget.24475. View

17.

Lagergren F, Xie S, Mattsson F, Lagergren J . Updated incidence trends in cardia and non-cardia gastric adenocarcinoma in Sweden. Acta Oncol. 2018; 57(9):1173-1178. DOI: 10.1080/0284186X.2018.1457797. View

18.

Pu X, Zhu L, Fu Y, Fan Z, Zheng J, Zhang B . Companied P16 genetic and protein status together providing useful information on the clinical outcome of urinary bladder cancer. Medicine (Baltimore). 2018; 97(15):e0353. PMC: 5908565. DOI: 10.1097/MD.0000000000010353. View

19.

Cao L, Liu Y, Wang D, Huang L, Li F, Liu J . MiR-760 suppresses human colorectal cancer growth by targeting BATF3/AP-1/cyclinD1 signaling. J Exp Clin Cancer Res. 2018; 37(1):83. PMC: 5902951. DOI: 10.1186/s13046-018-0757-8. View

20.

Chen G, Xu M, Chen J, Hong L, Lin W, Zhao S . Clinicopathological Features and Increased Expression of Toll-Like Receptor 4 of Gastric Cardia Cancer in a High-Risk Chinese Population. J Immunol Res. 2018; 2018:7132868. PMC: 5835293. DOI: 10.1155/2018/7132868. View